CD46 and neoplasm: MUC4,20 and AREG21 (ie, amphiregulin), previously described to be associated to CRC tumourigenesis, and the potentially novel biomarkers CD81, CD46 and SPINK5 were strongly deregulated in the epithelial segments of the tumours (figure 2C).